ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Plasma p-tau181 Level Predicts Neurodegeneration and Progression to Alzheimer's Dementia: A Longitudinal Study

Wang, Yan-Li; Chen, Jinglong; Du, Zhong-Li; Weng, Haoyi; Zhang, Yuan; Li, Runzhi; Jia, Ziyan; Sun, Mengfan; Jiang, Jiwei; Wang, Fang-Ze; Xu, Jun*中国医学科学院; 1
Frontiers in Neurology2021-9-7DOI: 10.3389/fneur.2021.695696
19被引7阅读
引用收藏
分享

摘要

Background: Plasma-based biomarkers would be potential biomarkers for early diagnosis of Alzheimer's disease (AD) because they are more available and cost-effective than cerebrospinal fluid (CSF) or neuroimaging. Therefore, we aimed to evaluate whether phosphorylated tau181 (p-tau181) in plasma could be an accurate AD predictor. @@@ Methods: Participants from the ADNI database included 185 cognitively unimpaired subjects with negative A beta (CU-), 66 subjects with pre-clinical AD (CU with positive A beta), 164 subjects with mild cognitive impairment with negative A beta (MCI-), 254 subjects with prodromal AD (MCI with positive A beta), and 98 subjects with dementia. Multiple linear regression models, linear mixed-effects models, and local regression were used to explore cross-sectional and longitudinal associations of plasma p-tau181 with cognition, neuroimaging, or CSF biomarkers adjusted for age, sex, education, and APOE genotype. Besides, Kaplan-Meier and adjusted Cox-regression model were performed to predict the risk of progression to dementia. Receiver operating characteristic analyses were performed to evaluate the predictive value of p-tau181. @@@ Results: Plasma p-tau181 level was highest in AD dementia, followed by prodromal AD and pre-clinical AD. In pre-clinical AD, plasma p-tau181 was negatively associated with hippocampal volume (beta = -0.031, p-value = 0.017). In prodromal AD, plasma p-tau181 was associated with decreased global cognition, executive function, memory, language, and visuospatial functioning (beta range -0.119 to -0.273, p-value < 0.05) and correlated with hippocampal volume (beta = -0.028, p-value < 0.005) and white matter hyperintensity volume (WMH) volume (beta = 0.02, p-value = 0.01). In AD dementia, increased plasma p-tau181 was associated with worse memory. In the whole group, baseline plasma p-tau181 was significantly associated with longitudinal increases in multiple neuropsychological test z-scores and correlated with AD-related CSF biomarkers and hippocampal volume (p-value < 0.05). Meanwhile, CU or MCI with high plasma p-tau181 carried a higher risk of progression to dementia. The area under the curve (AUC) of the adjusted model (age, sex, education, APOE genotype, and plasma p-tau181) was 0.78; that of additionally included CSF biomarkers was 0.84. @@@ Conclusions: Plasma p-tau181 level is related to multiple AD-associated cognitive domains and AD-related CSF biomarkers at the clinical stages of AD. Moreover, plasma p-tau181 level is related to the change rates of cognitive decline and hippocampal atrophy. Thus, this study confirms the utility of plasma p-tau181 as a non-invasive biomarker for early detection and prediction of AD.

学科与关键词

关键词
Alzheimer's diseaseplasma p-tau181cognitioncerebrospinal fluid (CSF)NeuroImage
相关
加载中…
  • Brain Gray Matter Volume Mediated the Correlation Between Plasma P-Tau and Cognitive Function of Early Alzheimer's Disease in China: A Cross-Sectional Observational Study
    Wan, Ke; Yin, Wenwen; Tang, Yating; Zhu, Wenhao; Wang, Zhiqiang; Zhou, Xia; Zhang, Wei; Zhang, Cun; Yu, Xianfeng; Zhao, Wenming; Li, Chenchen; Zhu, Xiaoqun; Sun, Zhongwu*JOURNAL OF ALZHEIMERS DISEASE, 2023, 92(1): 81-93.被引 1
  • 18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease
    Mattsson, Niklas*; Scholl, Michael; Strandberg, Olof; Smith, Ruben; Palmqvist, Sebastian; Insel, Philip S.; Hgerstrom, Douglas; Ohlsson, Tomas; Zetterberg, Henrik; Jogi, Jonas; Blennow, Kaj; Hansson, Oskar*EMBO Molecular Medicine, 2017, 9(9): 1212-1223.被引 145
  • Serum sirtuin1: a potential blood biomarker for early diagnosis of Alzheimer's disease
    Wang, Jia; Zhou, Fang; Xiong, Chang-E; Wang, Gui-Ping; Chen, Lin-Wanyue; Zhang, Yu -Tong; Qi, Shi-Ge; Wang, Zhi-Hui; Mei, Can; Xu, Yu-Jia; Zhan, Jian-Bo*; Cheng, Jing*Aging-US, 2023, 15(18): 9464-9478.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Neurology
发表日期
2021-09-07
卷期
第 12 卷
页码
695696
DOI
10.3389/fneur.2021.695696
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation [82071187, 81870821, 81471215]; Beijing Youth Talent Team Support Program [2018000021223TD08]

作者

  • W

    Wang, Yan-Li (第一作者)

    capital med univ

  • C

    Chen, Jinglong

    1

查看全部 11 位作者收起作者
  • D

    Du, Zhong-Li

    beijing hosp · chinese acad med sci

  • W

    Weng, Haoyi

  • Z

    Zhang, Yuan

    capital med univ

  • L

    Li, Runzhi

    capital med univ

  • J

    Jia, Ziyan

    capital med univ

  • S

    Sun, Mengfan

    capital med univ

  • J

    Jiang, Jiwei

    capital med univ

  • W

    Wang, Fang-Ze

    weifang peoples hosp

  • X

    Xu, Jun (通讯)

    capital med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417